Trial Profile
A single-arm, phase 2 study evaluating the efficacy and safety of combination of lenalidomide and R-ICE in patients of relapsed/refractory non-GCB subtype DLBCL previously treated with R-CHOP
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2018
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Etoposide (Primary) ; Ifosfamide (Primary) ; Lenalidomide (Primary) ; Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 27 Jun 2018 New trial record